We are live on ! Find out more
CLLS

Cellectis

57 hedge funds and large institutions have $213M invested in Cellectis in 2017 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 14 increasing their positions, 7 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

320% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 5

100% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 7

62% more call options, than puts

Call options by funds: $3.27M | Put options by funds: $2.02M

36% more funds holding

Funds holding: 4257 (+15)

28% more capital invested

Capital invested by funds: $167M → $213M (+$46M)

4.05% more ownership

Funds ownership: 16.58%20.63% (+4.1%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
57
Holders Change
+15
Holders Change %
+35.71%
% of All Funds
1.29%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
21
Increased
14
Reduced
7
Closed
5
Calls
$3.27M
Puts
$2.02M
Net Calls
+$1.25M
Net Calls Change
+$438K

CLLS Hedge Fund Activity: Q4 2017 in Review

57 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Cellectis (CLLS) for Q4 2017, worth a combined $213M — up 28% from $167M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new CLLS positions and 5 closed out — a net gain of 16 holders — while 14 added to existing stakes and 7 trimmed.

The largest buyer was Perceptive Advisors, opening a new position worth an estimated $9.53M. The largest seller was Farallon Capital Management, exiting entirely with an estimated $11M sold.

  • 57 institutional investors held Cellectis (CLLS) as of Q4 2017, up from 42 in Q3 2017.
  • Funds reported $213M of Cellectis stock for Q4 2017, up 28% quarter-over-quarter.
  • 21 funds opened new Cellectis positions in Q4 2017 and 5 closed out, a net change of +16 holders.
  • The largest Cellectis buyer in Q4 2017 was Perceptive Advisors, an estimated $9.53M added.
  • The largest Cellectis seller in Q4 2017 was Farallon Capital Management, an estimated $11M sold.

Based on aggregated 13F filings for Q4 2017.